Regorafenib in Indian Patients With Metastatic Colorectal Cancer (mCRC).

Clinical trial NCT03564938 · COMPLETED

Trial details

NCT number: NCT03564938
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2018-07-30
Primary completion: 2023-03-20
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.